Decoding 8 Analyst Evaluations For Arcellx
Portfolio Pulse from Benzinga Insights
Arcellx (NASDAQ:ACLX) received evaluations from 8 analysts, with 6 bullish and 2 somewhat bullish ratings. The average 12-month price target is $81.5, with a high of $87.00 and a low of $70.00. Recent analyst actions include maintaining, raising, and lowering ratings, reflecting their response to market dynamics and company performance. Arcellx has shown strong revenue growth and effective financial management, despite challenges in the healthcare sector.
July 22, 2024 | 2:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Arcellx received 8 analyst evaluations, with 6 bullish and 2 somewhat bullish ratings. The average 12-month price target is $81.5, with a high of $87.00 and a low of $70.00. Recent analyst actions include maintaining, raising, and lowering ratings, reflecting their response to market dynamics and company performance. Arcellx has shown strong revenue growth and effective financial management, despite challenges in the healthcare sector.
The majority of analysts have a bullish outlook on Arcellx, with a high average price target. The company's strong revenue growth and effective financial management further support a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100